Skip to main content
Clinical Trials/NCT01670188
NCT01670188TerminatedNot Applicable

Sequential Pneumatic Compression to Prevent PICC-related Upper Extremity Venous Thrombosis in Critically Ill Neurological Patients

Mayo Clinic1 site in 1 country78 target enrollmentStarted: August 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
78
Locations
1
Primary Endpoint
Number of Patients Who Experienced an Ultrasonographically-confirmed Venous Thrombosis

Study Overview

Brief Summary

The purpose of this study is to see if a compression device on the arm where a peripherally inserted central catheter (PICC) line has been inserted can prevent the formation of a blood clot around the PICC line.

Detailed Description

In a pilot prospective randomized controlled trial, consecutive patients requiring placement of a PICC line in the Neuroscience intensive care unit were randomly assigned to either the SCD (intervention) group or a non SCD (control) group.

Standardized vascular access patency protocols was used in all enrolled patients. All patients had an indwelling 5 French, double lumen PICC unless additional venous access was required by the primary service. Patients randomized to the intervention arm had an SCD placed in the arm with the PICC within 24 hours of PICC placement.

Five to seven days after placement of the PICC, the patients were examined with venous duplex ultrasound of the upper extremity to assess for the presence of venous thrombosis. The patients also had the ultrasound again 12-14 days post insertion if the PICC was kept for more than 10 days. If the PICC line was removed before 5-7 days, an upper extremity ultrasound was obtained upon PICC removal. In case of suspected symptomatic venous thromboembolism, the investigations were performed according to current practice standards. Data collection was be considered complete upon removal of the PICC line.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subject's age is greater than or equal to 18 years
  • •Subject is patient in neuro intensive care unit at time of PICC placement

Exclusion Criteria

  • •Acute trauma to the upper extremity harboring the PICC
  • •Current use of prophylactic anticoagulation
  • •Inability to fit the SCD on the arm because of arm size
  • •Documented previous upper extremity DVT in the arm harboring the PICC line

Arms & Interventions

Pneumatic SCD

Active Comparator

Use of pneumatic SCD (VenaFlow System - DJO Global) on upper extremity with PICC line inserted.

Intervention: Pneumatic SCD - VenaFlow System (DJO Global) (Device)

Non-SCD group

No Intervention

Standard care

Outcomes

Primary Outcomes

Number of Patients Who Experienced an Ultrasonographically-confirmed Venous Thrombosis

Time Frame: baseline to 14 days post insertion of PICC line

Ultrasonographically-confirmed upper extremity venous thrombosis (symptomatic and asymptomatic) in arm with PICC catheter

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alejandro Rabinstein

PI

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials